Sally Daub is Co-Founder, Chairman, and President at Altis Labs, a computational imaging company applying AI to accelerate oncology clinical trials and advance precision medicine.

A chemical engineering graduate of the University of Ottawa and law graduate of Dalhousie University, Sally began her career as a patent attorney before serving as VP and General Counsel at ATI Technologies.

Sally previously co-founded ViXS Systems in 2001, scaling it to $100M in revenue and a successful IPO, and was named one of Canada's Most Powerful Women Top 100 four times by the Women's Executive Network.

She also founded Pool Global Partners in 2016, a seed-stage venture capital firm focused on hard tech including quantum computing, deep learning, and AI, and served as a Founding Board Member of Quantum Industry Canada.

Altis Labs has raised $6M in seed funding and its Nota platform, trained on over 182 million real-world images, is used by leading biopharma companies including AstraZeneca and Bayer to de-risk clinical development.